Rein Therapeutics, Inc RNTX
NASDAQ · United States · Health Technology
$0.8550+0.05 (+6.34%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.10 | -0.17 | +41.2% | $0 | — | +6.7%$0.79→$0.84 |
| Q1 2026 | 2026-05-15 | -0.19 | -0.49 | +61.2% | — | — | -8.0%$1.13→$1.04 |
| Q4 2025 | 2026-03-26 | -1.22 | -0.21 | -481.0% | — | — | -3.8%$1.30→$1.25 |
| Q3 2025 | 2025-11-14 | -0.21 | -0.24 | +12.5% | — | — | -9.6%$1.35→$1.22 |
| Q4 2024 | 2025-04-07 | -2.20 | -0.12 | -1,733.3% | — | — | — |
| Q1 2024 | 2024-05-15 | -0.86 | -1.02 | +15.7% | — | — | — |
| Q4 2023 | 2024-04-15 | -1.54 | -0.16 | -862.5% | — | — | — |
| Q3 2023 | 2023-10-13 | -0.40 | -0.20 | -100.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.